Opioids, bribery and Wall Street: the inside story of a disgraced drugmaker [FT.com - Mergermarket]
AcelRx Pharmaceuticals, Inc. (ACRX)
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.acelrx.com/investor-relations
Company Research
Source: FT.com - Mergermarket
Hannah KuchlerShaunagh ConnaireNick VerbitskyAnnie WongTom JenningsJune 19, 2020Print this pageThis story is outside the FT’s paywall (you do not need a subscription to access it) so it can be shared freely.Deborah Fuller had just heard the sentences that were the closest she would get to justice.In March 2016, her daughter Sarah died from an overdose of drugs that included Subsys: a tiny yet potent spray containing fentanyl, an opioid 50 to 100 times stronger than morphine. The day before her death, mother and daughter had chatted about her upcoming wedding. Sarah had already bought a garter. Deborah was planning to sew her veil.The next morning, Sarah’s fiancé found her dead, keeled over on her face. “It was not a vision I would wish on anyone. We had to have her cremated because there was no way they could have made it so that she was recognisable,” Deborah recalls in an interview.The former nursing assistant had first become addicted to opioids when she was prescribed them for fib
Show less
Read more
Impact Snapshot
Event Time:
ACRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACRX alerts
High impacting AcelRx Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ACRX
News
- AcelRx Announces Rebranding With Name Change to Talphera, Inc. [Yahoo! Finance]Yahoo! Finance
- AcelRx Announces Rebranding With Name Change to Talphera, Inc.PR Newswire
- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
ACRX
Earnings
- 11/8/23 - Beat
ACRX
Sec Filings
- 1/9/24 - Form 8-K
- ACRX's page on the SEC website